Given the important role of LSD1 activity in regulating pro-fibrotic signalling in healthy dermal fibroblasts, we sought to determine the role of LSD1 in SSc patient-derived fibroblasts, which are primed to respond to TGF-β stimulation. The gene discussed is KDM1A; the disease is systemic sclerosis.